Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma, Intraductal, Noninfiltrating × darolutamide × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 8 Neoplasm Metastasis 1 High-Risk Localized Prostate Cancer 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

darolutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Radiotherapy 1 FAPI-46 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04176081 2024-01-24

SChLAP/IDC

University Health Network, Toronto

Phase 2 Not yet recruiting

BreastGenitourinary

Carcinoma, Intraductal, Noninfiltrating, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡